Session Information
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer in Singapore
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
All times listed are in Singapore time (GMT+8)
PL - Plenary
PS - Presidential Symposium
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
IS - Industry Symposium
JICC - Joint IASLC-CAALC-CSCO Session
January 28 Thu
Jan 28 Friday
January 29 Fri
Jan 29 Saturday
January 30 Sat
Jan 30 Sunday
January 31 Sun
Jan 31
-
+
IS08 - Industry Symposium Sponsored by Janssen Oncology: What the Future Holds for Advanced NSCLC Patients with Resistance to EGFR TKIs
- 13:00 - 14:00
- 1/29/2021
- Location: Industry Symposia Auditorium (via Industry Hub)
- Not for CME Credit
- Type: Industry Symposium
- Track:
-
+
IS08.01 - Welcome and Introductions
13:00 - 13:05 | Presenter: Tetsuya Mitsudomi
- Abstract
No abstract available for this presentation
-
+
IS08.02 - A Light at the End of the Tunnel - Hope for Patients With EGFR Exon20 Insertion Mutations
13:05 - 13:25 | Presenter: Byoung Chul Cho
- Abstract
No abstract available for this presentation
-
+
IS08.03 - The Dawn of a New Era - Novel Treatments for Patients With TKI Resistant Disease With Common EGFR Mutations
13:25 - 13:45 | Presenter: Enriqueta Felip
- Abstract
No abstract available for this presentation
-
+
IS08.04 - Live Q&A: From Information to Transformation - Navigating the Evidence With Experience Sharing in a Live Forum to Improve Patient Care
13:45 - 14:00
- Abstract
No abstract available for this presentation
-
+
IS09 - Industry Symposium Sponsored by Pfizer Oncology: Expert Question Time: ALK+ NSCLC
- 13:00 - 14:00
- 1/29/2021
- Location: Industry Symposia Auditorium (via Industry Hub)
- Not for CME Credit
- Type: Industry Symposium
- Track:
-
+
IS09.01 - Welcome and Introduction
13:00 - 13:05 | Presenter: Seng Weng Wong
- Abstract
No abstract available for this presentation
-
+
IS09.02 - Navigating Recent Clinical Data for ALK + TKIS
13:05 - 13:45 | Presenter: Thanyanan Reungwetwattana
- Abstract
No abstract available for this presentation
-
+
IS09.02 - Selecting Treatment and Management of ALK+ NSCLC
13:45 - 13:45 | Presenter: Nick Pavlakis
- Abstract
No abstract available for this presentation
-
+
IS09.02 - The Importance of Managing CNS Disease
13:45 - 13:45 | Presenter: John Chang
- Abstract
No abstract available for this presentation
-
+
IS09.02 - The Future of ALK+ NSCLC
13:45 - 13:45 | Presenter: Nir Peled
- Abstract
No abstract available for this presentation
-
+
IS09.03 - Q&A
13:45 - 13:58
- Abstract
No abstract available for this presentation
-
+
IS09.04 - Summary, Thank You and Close
13:58 - 14:00 | Presenter: Seng Weng Wong
- Abstract
No abstract available for this presentation
-
+
IS10 - Industry Symposium Sponsored by Bristol Myers Squibb: Thoracic Cancers, New Developments with IO
- 13:00 - 14:00
- 1/29/2021
- Location: Industry Symposia Auditorium (via Industry Hub)
- Not for CME Credit
- Type: Industry Symposium
- Track:
-
+
IS10.01 - Welcome and Introductions
13:00 - 13:05 | Presenter: Virginie Westeel
- Abstract
No abstract available for this presentation
-
+
IS10.02 - What Is the Role of IO in Non-Metastatic NSCLC?
13:05 - 13:20 | Presenter: Virginie Westeel
- Abstract
No abstract available for this presentation
-
+
IS10.03 - IO in the Treatment of Metastatic NSCLC, Where Are We Now?
13:20 - 13:35 | Presenter: Julie Brahmer
- Abstract
No abstract available for this presentation
-
+
IS10.04 - Non-Metastatic and Metastatic NSCLC Q&A
13:35 - 13:40 | Presenter: Virginie Westeel, Julie Brahmer
- Abstract
No abstract available for this presentation
-
+
IS10.05 - What Is I-O’s Impact on the Treatment Paradigm for Mesothelioma Patients?
13:40 - 13:55 | Presenter: Nicolas Girard
- Abstract
No abstract available for this presentation
-
+
IS10.06 - Mesothelioma Q&A and Closing Remarks
13:55 - 14:00 | Presenter: Nicolas Girard, Virginie Westeel
- Abstract
No abstract available for this presentation
-
+
ES05 - Value in Lung Cancer, from Screening to Treatment
- 14:15 - 15:15
- 1/29/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Health Services Research/Health Economics
-
+
ES05.01 - Chair
14:15 - 14:15 | Presenter: Antonio Calles
- Abstract
No abstract available for this presentation
-
+
ES05.02 - Chair
14:15 - 14:15 | Presenter: Lucinda Morris
- Abstract
No abstract available for this presentation
-
+
ES05.03 - Radiation Oncology: Value and Innovation
14:15 - 14:25 | Presenter: Fumiko Ladd Chino
- Abstract
Loading... -
+
ES05.04 - Lung Cancer Screening in Lower Resource Settings
14:25 - 14:35 | Presenter: Ricardo Santos
- Abstract
No abstract available for this presentation
-
+
ES05.05 - Age, Gender and Ethnicity: Disparities in Lung Cancer
14:35 - 14:45 | Presenter: Linda Coate
- Abstract
No abstract available for this presentation
-
+
ES05.06 - Molecular Testing, Targeted Agents and Immunotherapy in Lung Cancer: Are They Worth the Cost?
14:45 - 14:55 | Presenter: Gilberto Lopes
- Abstract
No abstract available for this presentation
-
+
ES05.07 - Defining Value and Common Sense in Lung Cancer
14:55 - 15:05 | Presenter: Bishal Gyawali
- Abstract
Loading... -
+
ES05.08 - Live Q&A
15:05 - 15:15
- Abstract
No abstract available for this presentation
-
+
ES06 - Perioperative Therapy for Early Stage NSCLC
- 14:15 - 15:15
- 1/29/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Early Stage/Localized Disease
-
+
ES06.01 - Neoadjuvant IO Monotherapy vs. Chemo-IO
14:15 - 14:30 | Presenter: Mariano Provencio
- Abstract
Loading... -
+
ES06.02 - Radiation and IO for Operable Early Stage NSCLC
14:30 - 14:45 | Presenter: Suresh Senan
- Abstract
Loading... -
+
ES06.03 - Neoadjvuant and Adjuvant Targeted Therapies
14:45 - 15:00 | Presenter: Wen-zhao Zhong
- Abstract
No abstract available for this presentation
-
+
ES06.04 - MPR and pCR as Primary Endpoints in Neoadjuvant Trials
15:00 - 15:15 | Presenter: Noriko Motoi
- Abstract
Loading...
-
+
MA02 - Technological Advances in Diagnostics, Imaging and Therapeutics for Lung Cancer
- 14:15 - 15:15
- 1/29/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Diagnostics and Interventional Pulmonology
-
+
MA02.01 - Chair
14:15 - 14:15 | Presenter: Pieter Edsge Postmus
- Abstract
No abstract available for this presentation
-
+
MA02.02 - Chair
14:15 - 14:15 | Presenter: David Paul Carbone
- Abstract
No abstract available for this presentation
-
+
MA02.04 - Initial Experience of Hybrid Operating Room Cone-Beam CT Guided Bronchoscopic Microwave Thermal Ablation of Peripheral Small Lung Lesions
14:15 - 14:20 | Presenter: Joyce Chan
- Abstract
Loading... -
+
MA02.05 - NAVIGATE 24-Month Results: Electromagnetic Navigation Bronchoscopy for Pulmonary Lesions at 37 Centers in Europe and the US
14:20 - 14:25 | Presenter: Erik Folch
- Abstract
Loading... -
+
MA02.07 - Discussant
14:25 - 14:30 | Presenter: Kazuhiro Yasufuku
- Abstract
No abstract available for this presentation
-
+
MA02.08 - Computed Tomography Attenuation Value as Considerable Predictor for Malignancy in Clinical T1 Lung Adenocarcinoma
14:30 - 14:35 | Presenter: Zhen-Bin Qiu
- Abstract
Loading... -
+
MA02.09 - Analysis of Targets for Lung Stereotactic Body Radiotherapy with Clinical Four Dimension (4D) Computed Tomography (CT)
14:35 - 14:40 | Presenter: Kaile Li
- Abstract
Loading... -
+
MA02.10 - Deriving Pulmonary Perfusion Images from 4DCT Using Deep Learning
14:40 - 14:45 | Presenter: Daniela Lozano
- Abstract
Loading... -
+
MA02.11 - Timing and Site-specific Recurrence Pattern for Resected Lung Adenocarcinoma and Association with Driver Gene Mutations
14:45 - 14:50 | Presenter: Deng Chaoqiang
- Abstract
Loading... -
+
MA02.12 - Discussant
14:50 - 14:55 | Presenter: Tobias Peikert
- Abstract
No abstract available for this presentation
-
+
MA02.13 - Live Q&A
14:55 - 15:15
- Abstract
No abstract available for this presentation
-
+
ES07 - Pleural Effusion in a Cancer Patient
- 15:30 - 16:30
- 1/29/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Diagnostics and Interventional Pulmonology
-
+
ES07.01 - Radiological Evaluation of Pleural Effusion in a Cancer Patient
15:30 - 15:45 | Presenter: Yeun-Chung Chang
- Abstract
Loading... -
+
ES07.02 - Role of Pleural Fluid Molecular Markers and PD-L1 Testing
15:45 - 16:00 | Presenter: Zoltan Lohinai
- Abstract
Loading... -
+
ES07.03 - Malignant Pleural Effusion: Patient Presentation and Diagnostic Pathway
16:00 - 16:15 | Presenter: Laura McNaughton
- Abstract
No abstract available for this presentation
-
+
ES07.04 - Chemical Pleurodesis, Indwelling Pleural Catheter or Both for Malignant Pleural Effusion
16:15 - 16:30 | Presenter: Pyng Lee
- Abstract
No abstract available for this presentation
-
+
MA03 - New and Revisited Prognostic Factors in Early Stage Lung Cancer
- 15:30 - 16:30
- 1/29/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Early Stage/Localized Disease
-
+
MA03.01 - Chair
15:30 - 15:30 | Presenter: Peter Licht
- Abstract
No abstract available for this presentation
-
+
MA03.02 - Chair
15:30 - 15:30 | Presenter: Eric Lim
- Abstract
No abstract available for this presentation
-
+
MA03.03 - Subsolid Lesions Exceeding 3cm: Do the Ground-Glass Opacity Components Still Matter?
15:30 - 15:35 | Presenter: fan fan Fan
- Abstract
Loading... -
+
MA03.04 - Gender-specific Radiomics Models for Predicting Recurrence in Early Stage (Stage I, II) Non-Small Cell Lung Cancer (ES-NSCLC) Patients
15:35 - 15:40 | Presenter: Pranjal Vaidya
- Abstract
Loading... -
+
MA03.05 - Hierarchy of Adverse-Prognosis Quality Markers after Curative-Intent Resection of Non-Small Cell Lung Cancer (NSCLC)
15:40 - 15:45 | Presenter: Ray Uyiosa Osarogiagbon
- Abstract
Loading... -
+
MA03.06 - Health-Related Quality of Life in Lung Cancer Patients Undergoing Thoracic Surgery
15:45 - 15:50 | Presenter: Eagan Peters
- Abstract
Loading... -
+
MA03.07 - Discussant
15:50 - 15:55 | Presenter: Wentao Fang
- Abstract
No abstract available for this presentation
-
+
MA03.08 - Impact of COVID-19 Pandemic in the Diagnosis and Prognosis of Lung Cancer
15:55 - 16:00 | Presenter: Roxana Reyes
- Abstract
Loading... -
+
MA03.09 - Can Clinical Variables be used to Provide Better Follow up in Stereotactic Ablative Radiotherapy (SABR) Treated Lung Cancers?
16:00 - 16:05 | Presenter: Nathaniel Luke Hatton
- Abstract
Loading... -
+
MA03.10 - Venous Thromboembolism in Lung Cancer Patients: A Population-Based Study
16:05 - 16:10 | Presenter: Gilly Akhtar-Danesh
- Abstract
Loading... -
+
MA03.11 - Cognitive Bias in Lung Cancer Surgery: The Left Digit Effect
16:10 - 16:15 | Presenter: Chi-fu Jeffrey Yang
- Abstract
Loading... -
+
MA03.12 - Discussant
16:15 - 16:20 | Presenter: Jay M. Lee
- Abstract
No abstract available for this presentation
-
+
MA03.13 - Live Q&A
16:20 - 16:30
- Abstract
No abstract available for this presentation
-
+
OA05 - Value and Quality in Lung Cancer
- 15:30 - 16:30
- 1/29/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Health Services Research/Health Economics
-
+
OA05.01 - Chair
15:30 - 15:30 | Presenter: Narjust Duma
- Abstract
No abstract available for this presentation
-
+
OA05.02 - Chair
15:30 - 15:30 | Presenter: CS Pramesh
- Abstract
No abstract available for this presentation
-
+
OA05.03 - Real-World Global Data on Targeting Epidermal Growth Factor Receptor in Stage III Non-Small Cell Lung Cancer: The Results of the KINDLE Study
15:30 - 15:40 | Presenter: Abdul Rahman Jazieh
- Abstract
Loading... -
+
OA05.04 - Clinical and Economic Impact of the Current Testing Scenario for ALK Rearrangements in Spain Compared to a Hypothetical No-Testing Scenario.
15:40 - 15:50 | Presenter: Ana Laura Ortega Granados
- Abstract
Loading... -
+
OA05.05 - Economic Impact of Next-Generation Sequencing (NGS) vs. Single-gene Testing Strategies to Detect Genomic Alterations (GAs) in mNSCLC in Asia
15:50 - 16:00 | Presenter: Herbert H Loong
- Abstract
Loading... -
+
OA05.06 - Lessons Learned from the Victorian Lung Cancer Registry: Opportunities for Quality Improvement in Lung Cancer Management and Outcomes
16:00 - 16:10 | Presenter: Rob G Stirling
- Abstract
Loading... -
+
OA05.07 - Discussant
16:10 - 16:20 | Presenter: Doreen A Ezeife
- Abstract
No abstract available for this presentation
-
+
OA05.08 - Live Q&A
16:20 - 16:30
- Abstract
No abstract available for this presentation
-
+
ES08 - The Solitary Pulmonary Nodule
- 16:45 - 17:45
- 1/29/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Diagnostics and Interventional Pulmonology
-
+
ES08.01 - Chair
16:45 - 16:45 | Presenter: Haja Mohideen Salahudeen Mohamed
- Abstract
No abstract available for this presentation
-
+
ES08.02 - Chair
16:45 - 16:45 | Presenter: Martin Johnston Phillips
- Abstract
No abstract available for this presentation
-
+
ES08.03 - Evidence Based Evaluation of the Indeterminant Pulmonary Nodule
16:45 - 16:57 | Presenter: Annette McWilliams
- Abstract
No abstract available for this presentation
-
+
ES08.04 - Biomarkers in the Evaluation of Pulmonary Nodule
16:57 - 17:09 | Presenter: James R Jett
- Abstract
Loading... -
+
ES08.05 - Targeting the SPN
17:09 - 17:21 | Presenter: Kwun Fong
- Abstract
No abstract available for this presentation
-
+
ES08.06 - Bronchoscopic Treatment of SPN: Opportunities and Challenges
17:21 - 17:33 | Presenter: David Feller-Kopman
- Abstract
No abstract available for this presentation
-
+
ES08.07 - Live Q&A
17:33 - 17:45
- Abstract
No abstract available for this presentation